OBJECT: Thalamic tumors represent only 1 to 5% of brain neoplasms but frequently affect children. However, pediatric series are rare and go back to several years in spite of recent advances in the neuroradiological, pathological, and molecular fields. METHODS: We report a series of 14 pediatric thalamic gliomas with clinical, neuroradiological, and pathological studies including p53 immunostaining in 11 cases and 1p19q status in three cases. RESULTS: Our series included five pilocytic astrocytomas, seven oligodendrogliomas, and two glioblastomas. Pilocytic astrocytomas were characterized by strong contrast enhancement, lack of p53 expression, and excellent prognosis. Oligodendrogliomas frequently demonstrated an aspect of unilateral thalamic enlargement lacking or with slight contrast enhancement. Some of them expressed p53 or demonstrated 1p loss. Anaplastic oligodendrogliomas and glioblastomas displayed a poor outcome, with a mean survival of 8 months after surgery. CONCLUSION: Our series of pediatric thalamic gliomas clearly distinguishes pilocytic astrocytomas from anaplastic oligodendrogliomas regarding neuroimaging, pathology, and prognosis.
OBJECT: Thalamic tumors represent only 1 to 5% of brain neoplasms but frequently affect children. However, pediatric series are rare and go back to several years in spite of recent advances in the neuroradiological, pathological, and molecular fields. METHODS: We report a series of 14 pediatric thalamic gliomas with clinical, neuroradiological, and pathological studies including p53 immunostaining in 11 cases and 1p19q status in three cases. RESULTS: Our series included five pilocytic astrocytomas, seven oligodendrogliomas, and two glioblastomas. Pilocytic astrocytomas were characterized by strong contrast enhancement, lack of p53 expression, and excellent prognosis. Oligodendrogliomas frequently demonstrated an aspect of unilateral thalamic enlargement lacking or with slight contrast enhancement. Some of them expressed p53 or demonstrated 1p loss. Anaplastic oligodendrogliomas and glioblastomas displayed a poor outcome, with a mean survival of 8 months after surgery. CONCLUSION: Our series of pediatric thalamic gliomas clearly distinguishes pilocytic astrocytomas from anaplastic oligodendrogliomas regarding neuroimaging, pathology, and prognosis.
Authors: Ravi Raghavan; Jyoti Balani; Arie Perry; Linda Margraf; Mary B Vono; Dan X Cai; Robert E Wyatt; Elisabeth J Rushing; Daniel C Bowers; Linda S Hynan; Charles L White Journal: J Neuropathol Exp Neurol Date: 2003-05 Impact factor: 3.685
Authors: Cesare Colosimo; Giuseppe Maria di Lella; Tommaso Tartaglione; Riccardo Riccardi Journal: Childs Nerv Syst Date: 2002-07-30 Impact factor: 1.475
Authors: Paul Steinbok; Chittur Viswanathan Gopalakrishnan; Alexander R Hengel; Aleksander M Vitali; Ken Poskitt; Cynthia Hawkins; James Drake; Maria Lamberti-Pasculli; Olufemi Ajani; Walter Hader; Vivek Mehta; P Daniel McNeely; Patrick J McDonald; Adrianna Ranger; Michael Vassilyadi; Jeff Atkinson; Scott Ryall; David D Eisenstat; Juliette Hukin Journal: Childs Nerv Syst Date: 2015-11-23 Impact factor: 1.475
Authors: Tineke Boesten; Nicolas U Gerber; Daniela Kandels; Amedeo A Azizi; Rene Schmidt; Monika Warmuth-Metz; Torsten Pietsch; Rolf-Dieter Kortmann; Astrid Gnekow; Michael A Grotzer Journal: Neurooncol Pract Date: 2016-12-09
Authors: Christian Dorfer; Thomas Czech; Johannes Gojo; Arthur Hosmann; Andreas Peyrl; Amedeo A Azizi; Gregor Kasprian; Karin Dieckmann; Mariella G Filbin; Christine Haberler; Karl Roessler; Irene Slavc Journal: Acta Neurochir (Wien) Date: 2020-10-22 Impact factor: 2.216
Authors: Scott Ryall; Rahul Krishnatry; Anthony Arnoldo; Pawel Buczkowicz; Matthew Mistry; Robert Siddaway; Cino Ling; Sanja Pajovic; Man Yu; Joshua B Rubin; Juliette Hukin; Paul Steinbok; Ute Bartels; Eric Bouffet; Uri Tabori; Cynthia Hawkins Journal: Acta Neuropathol Commun Date: 2016-08-31 Impact factor: 7.801